Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome P450, family 3, subfamily A, polypeptide 4 | Starlite/ChEMBL | No references |
Homo sapiens | ubiquitin specific peptidase 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | ubiquitin specific protease, putative | ubiquitin specific peptidase 2 | 362 aa | 378 aa | 25.7 % |
Brugia malayi | cytochrome P450 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 502 aa | 492 aa | 24.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.1337 | 0.1191 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0056 | 0.2346 | 0.3452 |
Brugia malayi | Ubiquitin carboxyl-terminal hydrolase family protein | 0.0045 | 0.1694 | 0.2492 |
Leishmania major | ubiquitin hydrolase, putative,cysteine peptidase, Clan CA, family C19, putative | 0.0045 | 0.1694 | 1 |
Echinococcus multilocularis | geminin | 0.0191 | 1 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0056 | 0.2346 | 0.3452 |
Echinococcus granulosus | ubiquitin carboxyl terminal hydrolase 8 | 0.0045 | 0.1694 | 0.1554 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.2346 | 0.3452 |
Trichomonas vaginalis | Clan CA, family C19, ubiquitin hydrolase-like cysteine peptidase | 0.0045 | 0.1694 | 0.5 |
Echinococcus multilocularis | TRP (transient receptor potential) channel | 0.0041 | 0.1466 | 0.1323 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0165 | 0.0243 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0018 | 0.0165 | 0.0243 |
Schistosoma mansoni | hypothetical protein | 0.0191 | 1 | 1 |
Trypanosoma cruzi | ubiquitin carboxyl-terminal hydrolase, putative | 0.0045 | 0.1694 | 1 |
Echinococcus multilocularis | ubiquitin carboxyl terminal hydrolase 8 | 0.0045 | 0.1694 | 0.1554 |
Echinococcus granulosus | TRP transient receptor potential channel | 0.0041 | 0.1466 | 0.1323 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0056 | 0.2346 | 0.3452 |
Schistosoma mansoni | transient receptor potential channel | 0.0109 | 0.5367 | 0.529 |
Schistosoma mansoni | ubiquitin-specific peptidase 2 (C19 family) | 0.0045 | 0.1694 | 0.1554 |
Echinococcus multilocularis | short transient receptor potential channel 6 | 0.0072 | 0.3264 | 0.3151 |
Brugia malayi | Transient-receptor-potential like protein | 0.0041 | 0.1466 | 0.2157 |
Trypanosoma cruzi | ubiquitin carboxyl-terminal hydrolase, putative | 0.0045 | 0.1694 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0134 | 0.6796 | 1 |
Brugia malayi | hypothetical protein | 0.0041 | 0.1458 | 0.2146 |
Echinococcus multilocularis | short transient receptor potential channel 6 | 0.0072 | 0.3264 | 0.3151 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0015 | 0 | 0.5 |
Trichomonas vaginalis | Clan CA, family C19, ubiquitin hydrolase-like cysteine peptidase | 0.0045 | 0.1694 | 0.5 |
Echinococcus granulosus | Peptidase C19 ubiquitin carboxyl terminal hydrolase 2 | 0.0045 | 0.1694 | 0.1554 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0018 | 0.0165 | 0.0243 |
Echinococcus granulosus | short transient receptor potential channel 6 | 0.0072 | 0.3264 | 0.3151 |
Echinococcus granulosus | transient receptor potential gamma protein | 0.0109 | 0.5367 | 0.529 |
Echinococcus multilocularis | transient receptor potential ion channel A | 0.0106 | 0.516 | 0.5079 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.1458 | 0.1315 |
Schistosoma mansoni | hypothetical protein | 0.0191 | 1 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0038 | 0.1337 | 0.1967 |
Loa Loa (eye worm) | hypothetical protein | 0.0109 | 0.5367 | 0.7898 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0134 | 0.6796 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0134 | 0.6796 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0041 | 0.1458 | 0.1315 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0018 | 0.0165 | 0.0243 |
Schistosoma mansoni | ubiquitin-specific peptidase 8 (C19 family) | 0.0045 | 0.1694 | 0.1554 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.1337 | 0.1967 |
Echinococcus multilocularis | ubiquitin specific protease 41 | 0.0045 | 0.1694 | 0.1554 |
Echinococcus granulosus | transient receptor potential ion channel A | 0.0106 | 0.516 | 0.5079 |
Giardia lamblia | Ubiquitin carboxyl-terminal hydrolase 4 | 0.0045 | 0.1694 | 0.5 |
Echinococcus granulosus | short transient receptor potential channel 6 | 0.0072 | 0.3264 | 0.3151 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.1466 | 0.2157 |
Loa Loa (eye worm) | hypothetical protein | 0.0045 | 0.1694 | 0.2492 |
Schistosoma mansoni | transient receptor potential channel | 0.0072 | 0.3264 | 0.3151 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0041 | 0.1458 | 0.1315 |
Schistosoma mansoni | transient receptor potential channel 4 | 0.0109 | 0.5367 | 0.529 |
Entamoeba histolytica | ubiquitin carboxyl-terminal hydrolase domain containing protein | 0.0045 | 0.1694 | 1 |
Schistosoma mansoni | transient receptor potential channel | 0.0072 | 0.3264 | 0.3151 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.1259 | 0.1852 |
Trypanosoma brucei | ubiquitin carboxyl-terminal hydrolase, putative | 0.0045 | 0.1694 | 1 |
Echinococcus multilocularis | transient receptor potential gamma protein | 0.0109 | 0.5367 | 0.529 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0045 | 0.1694 | 0.5 |
Echinococcus multilocularis | Peptidase C19, ubiquitin carboxyl terminal hydrolase 2 | 0.0045 | 0.1694 | 0.1554 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0041 | 0.1458 | 0.1315 |
Loa Loa (eye worm) | hypothetical protein | 0.0069 | 0.3057 | 0.4498 |
Echinococcus granulosus | ubiquitin specific protease 41 | 0.0045 | 0.1694 | 0.1554 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AC50 (functional) | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference | |
AC50 (functional) | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference | |
AC50 (functional) | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference | |
AC50 (functional) | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference | |
AC50 (functional) | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference | |
Potency (functional) | = 6.3096 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (ADMET) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ] | ChEMBL. | No reference |
Potency (ADMET) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.